arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Capricor Therapeutics, Inc.

CAPR Health Care Biotechnology: Pharmaceutical Preparations
$5.93
▲ +0.8% Today
as of Oct 23, 16:47 ET
Last 30 days -32.69% Sep 14 → Oct 23
$5.59 $6.63 $7.68 $8.72 $9.76 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$5.81
High
$6.35
Low
$5.80
Volume
$3M
Avg Vol
$3M
Mkt Cap
$520M
P/E (TTM)
—
Beta
—
52w High
$40.37
52w Low
$2.96
Div Yield
—
Shares Out
$58M

Recent Press Releases & News last 60 days · 19 items

Oct 21 · 19:52 Stocktwits
CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears
Oct 7 · 23:30 Stocktwits
CAPR Stock Rises Nearly 5% As Capricor Presents Heart Data For Deramiocel Ahead Of November FDA Decision
Oct 7 · 23:02 MarketBeat
Capricor Highlights Two-Year Deramiocel Data as FDA Decision Nears
▸ Show all 19 press releases & news Free account →

CAPR earnings at a glance

The options market is pricing a move of about ±7.5% after the report, a range of roughly $5.49 to $6.37 from today's $5.93. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.9% on average; after the most recent report on May 12, 2026 it moved -1.2%. That means options currently expect more movement than CAPR has typically delivered. CAPR beat the consensus EPS estimate in 0 of its last 4 reported quarters. Implied volatility is currently 179%. The share price of $5.93 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.96
$40
8% of range
Avg surprise (last 4)
-21.7%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
179%
EM ±7.5% · $8 · Oct 9

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.70$-0.59$-0.47$-0.36$-0.25 Actual $-0.31Actual $-0.29Actual $-0.25Actual $-0.31Actual $-0.35Actual $-0.38Actual $-0.53Est $-0.33Actual $-0.57Est $-0.48Actual $-0.54Est $-0.54Actual $-0.59Est $-0.55Actual $-0.70 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-41M$-30M$-19M$-8M$2M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.70 — — — — financials
Tue May 12, 2026Mar/2026 $-0.59 $-0.55 -7.3% -11.3% -1.2% earnings
Mon Nov 10, 2025Sep/2025 $-0.54 $-0.54 0.0% — — earnings
Mon Aug 11, 2025Jun/2025 $-0.57 $-0.48 -18.8% — — earnings
Tue May 13, 2025Mar/2025 $-0.53 $-0.33 -60.6% — +2.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.38 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.35 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.31 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.29 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.31 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue———————$2M
Cost of revenue————————
Gross profit————————
Operating income$-43M$-37M—$-26M$-28M$-25M—$-13M
Net income$-41M$-34M—$-25M$-26M$-24M—$-13M
EPS (diluted)$-0.70$-0.59—$-0.54$-0.57$-0.53—$-0.38

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$21M$105M$288M$20M$23M$29M$11M$68M
Inventory————————
Total current assets$242M$283M$323M$101M$124M$146M$163M$86M
Total assets$369M$326M$356M$126M$134M$154M$170M$93M
Long-term debt————————
Total liabilities$123M$48M$50M$43M$29M$26M$25M$25M
Total equity$246M$279M$306M$84M$105M$128M$145M$68M

Implied volatility — last 90 days

68%243%417%592%767% Jun 07 — IV 107% · EM ±14.9%Jun 08 — IV 130% · EM ±17.2%Jun 09 — IV 116% · EM ±14.6%Jun 10 — IV 97% · EM ±11.4%Jun 11 — IV 82% · EM ±9.1%Jun 12 — IV 99% · EM ±10.1%Jun 15 — IV 164% · EM ±11.9%Jun 16 — IV 148% · EM ±8.7%Jun 17 — IV 116% · EM ±4.8%Jun 19 — IV 82% · EM ±18.1%Jun 22 — IV 95% · EM ±19.8%Jun 23 — IV 99% · EM ±20.2%Jun 24 — IV 102% · EM ±20.3%Jun 25 — IV 93% · EM ±18.3%Jun 26 — IV 116% · EM ±22.2%Jun 29 — IV 109% · EM ±19.4%Jun 30 — IV 113% · EM ±19.4%Jul 01 — IV 123% · EM ±20.5%Jul 02 — IV 124% · EM ±20.0%Jul 03 — IV 128% · EM ±20.0%Jul 06 — IV 110% · EM ±15.3%Jul 07 — IV 184% · EM ±24.3%Jul 08 — IV 126% · EM ±15.8%Jul 09 — IV 156% · EM ±18.4%Jul 10 — IV 203% · EM ±22.4%Jul 13 — IV 120% · EM ±10.0%Jul 14 — IV 127% · EM ±9.2%Jul 15 — IV 424% · EM ±25.1%Jul 16 — IV 607% · EM ±25.4%Jul 20 — IV 331% · EM ±78.2%Jul 21 — IV 316% · EM ±73.5%Jul 22 — IV 327% · EM ±74.8%Jul 23 — IV 312% · EM ±70.1%Jul 24 — IV 334% · EM ±73.9%Jul 27 — IV 396% · EM ±82.7%Jul 28 — IV 348% · EM ±71.2%Jul 30 — IV 297% · EM ±58.2%Jul 31 — IV 256% · EM ±49.1%Aug 03 — IV 294% · EM ±52.1%Aug 04 — IV 232% · EM ±40.0%Aug 05 — IV 262% · EM ±43.7%Aug 06 — IV 246% · EM ±39.8%Aug 07 — IV 278% · EM ±43.4%Aug 10 — IV 300% · EM ±41.6%Aug 11 — IV 284% · EM ±37.5%Aug 12 — IV 305% · EM ±38.2%Aug 13 — IV 356% · EM ±42.1%Aug 14 — IV 307% · EM ±34.0%Aug 17 — IV 341% · EM ±28.5%Aug 18 — IV 360% · EM ±26.1%Aug 19 — IV 472% · EM ±27.9%Aug 20 — IV 460% · EM ±19.2%Aug 24 — IV 116% · EM ±24.3%Aug 25 — IV 117% · EM ±23.9%Aug 26 — IV 127% · EM ±25.5%Aug 28 — IV 306% · EM ±33.9%Aug 31 — IV 133% · EM ±11.1%Sep 01 — IV 199% · EM ±14.4%Sep 02 — IV 137% · EM ±8.1%Sep 03 — IV 310% · EM ±12.9%Sep 07 — IV 127% · EM ±10.6%Sep 09 — IV 69% · EM ±4.1%Sep 14 — IV 102% · EM ±8.5%Sep 15 — IV 121% · EM ±8.8%Sep 16 — IV 494% · EM ±29.2%Sep 17 — IV 114% · EM ±4.8%Sep 21 — IV 91% · EM ±7.6%Sep 28 — IV 152% · EM ±36.0%Sep 29 — IV 254% · EM ±59.2%Sep 30 — IV 130% · EM ±7.7%Oct 01 — IV 134% · EM ±5.6%Oct 06 — IV 767% · EM ±55.5%Oct 07 — IV 161% · EM ±9.5%Oct 08 — IV 179% · EM ±7.5%

Sector peers

OCS
Oculis Holding AG
$508M $7.90+0.4%
PBYI
Puma Biotechnology Inc
$506M $11.02+1.1%
CBIO
Crescent Biopharma, Inc.
$501M $12.82-2.7%
ACRS
Aclaris Therapeutics, Inc.
$500M $3.75-1.6%
ARVN
Arvinas, Inc.
$487M $7.30-3.4%
CTMX
CytomX Therapeutics, Inc.
$556M $2.32-3.3%

CAPR earnings FAQ

What is CAPR's expected move for earnings?

Options currently price a move of about ±7.5%, or $0.44 per share either way from $5.93.

How does CAPR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.9%, up 1 times and down 1 times.

What is CAPR's implied volatility?

CAPR's at-the-money implied volatility is about 179% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in